The six lines are all based on U2OS human osteosarcoma cells and share mutations in the ectopic RPB1 sequence that make it resistant to the toxin α-amanitin, which binds wildtype Pol II, preventing nucleotide incorporation and translocation, ultimately triggering the ubiquitination and degradation of the bound RPB1.31 Here, POLR2A is linked to osteosarcoma.